ATE408145T1 - Verfahren zum nachweis von nierenkrankheiten und zur pathologischen überwachung - Google Patents

Verfahren zum nachweis von nierenkrankheiten und zur pathologischen überwachung

Info

Publication number
ATE408145T1
ATE408145T1 AT99940663T AT99940663T ATE408145T1 AT E408145 T1 ATE408145 T1 AT E408145T1 AT 99940663 T AT99940663 T AT 99940663T AT 99940663 T AT99940663 T AT 99940663T AT E408145 T1 ATE408145 T1 AT E408145T1
Authority
AT
Austria
Prior art keywords
synthase
concentration
subject
determining
body fluid
Prior art date
Application number
AT99940663T
Other languages
English (en)
Inventor
Hiroshi Oda
Kosuke Seiki
Hiroshi Nakajima
Nobuyuki Sato
Yoshihiro T Urade
Nobuhito Hirawa
Yoshio Uehara
Original Assignee
Maruha Nichiro Seafoods Inc
Osaka Bioscience Inst
Japan Science & Tech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruha Nichiro Seafoods Inc, Osaka Bioscience Inst, Japan Science & Tech Corp filed Critical Maruha Nichiro Seafoods Inc
Application granted granted Critical
Publication of ATE408145T1 publication Critical patent/ATE408145T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
AT99940663T 1998-09-04 1999-09-03 Verfahren zum nachweis von nierenkrankheiten und zur pathologischen überwachung ATE408145T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25145098 1998-09-04
JP13305099A JP3961152B2 (ja) 1998-09-04 1999-05-13 腎疾患の検出および病態管理方法

Publications (1)

Publication Number Publication Date
ATE408145T1 true ATE408145T1 (de) 2008-09-15

Family

ID=26467489

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99940663T ATE408145T1 (de) 1998-09-04 1999-09-03 Verfahren zum nachweis von nierenkrankheiten und zur pathologischen überwachung

Country Status (9)

Country Link
US (1) US7109044B1 (de)
EP (1) EP1111387B1 (de)
JP (1) JP3961152B2 (de)
KR (1) KR100705732B1 (de)
AT (1) ATE408145T1 (de)
AU (1) AU750574B2 (de)
CA (1) CA2342897A1 (de)
DE (1) DE69939544D1 (de)
WO (1) WO2000014543A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0217402D0 (en) * 2002-07-26 2002-09-04 Roslin Inst Edinburgh Multi-reporter gene model for toxicological screening
US20040121489A1 (en) * 2002-08-29 2004-06-24 Dharnidharka Vikas R. COX-2 mediated altered prostaglandin balance in diabetes complications
JP2004108914A (ja) * 2002-09-18 2004-04-08 Kudo Norio コラーゲンの測定方法
JP3897117B2 (ja) * 2003-09-24 2007-03-22 マルハ株式会社 妊娠中毒症の重症度判定と予知方法、および妊娠中毒症における胎児・胎盤機能の評価方法
JP4354954B2 (ja) * 2003-09-26 2009-10-28 株式会社マルハニチロ水産 関節リウマチの検出又は鑑別方法及び病期又は機能障害度の判別方法
JP4871173B2 (ja) * 2007-03-06 2012-02-08 三菱化学メディエンス株式会社 糖尿病性腎症患者の病態把握方法
EP2153234A2 (de) * 2007-05-11 2010-02-17 The Institutes for Pharmaceutical Discovery, LLC Verfahren zur frühdiagnose einer nierenerkrankung
JP5757626B2 (ja) * 2009-09-04 2015-07-29 国立大学法人東北大学 ヒトにおける新たな腎疾患マーカー物質
DE102012018076B4 (de) 2012-09-13 2014-06-12 Lohmann Gmbh & Co. Kg Klebender Funktionsstreifen zur transkutanen Fluoreszenzmessung sowie zugehörige Herstellungsverfahren und Verwendungen
ES2690782T3 (es) 2012-10-24 2018-11-22 Nyu Winthrop Hospital Biomarcador no invasivo para identificar sujetos en riesgo de parto prematuro
JP5841644B2 (ja) * 2014-07-30 2016-01-13 シスメックス株式会社 尿検査方法および尿検査装置
CA3075688A1 (en) 2017-09-13 2019-03-21 Progenity, Inc. Preeclampsia biomarkers and related systems and methods
CN108918571B (zh) * 2018-06-15 2021-02-02 山西大学 代谢标志物在制备肾病综合征病变进程诊断鉴别试剂中的应用
EP4070113A4 (de) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor
CN119069129B (zh) * 2024-11-05 2025-03-04 长春中医药大学 慢性肾病健康状态智能分析预测预警方法及系统

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6122540A (en) * 1994-06-08 2000-09-19 The Regents Of The University Of California Noninvasive measurement of renal hemodynamic functions using magnetic resonance imaging
WO1997016461A1 (en) * 1995-10-31 1997-05-09 Maruha Corporation Monoclonal antibody specific for prostaglandin d synthetase

Also Published As

Publication number Publication date
DE69939544D1 (de) 2008-10-23
JP3961152B2 (ja) 2007-08-22
US7109044B1 (en) 2006-09-19
KR100705732B1 (ko) 2007-04-09
AU5449199A (en) 2000-03-27
EP1111387A1 (de) 2001-06-27
CA2342897A1 (en) 2000-03-16
AU750574B2 (en) 2002-07-25
JP2000146980A (ja) 2000-05-26
EP1111387A4 (de) 2002-08-21
EP1111387B1 (de) 2008-09-10
KR20010078380A (ko) 2001-08-20
WO2000014543A1 (en) 2000-03-16

Similar Documents

Publication Publication Date Title
DE69939544D1 (de) Verfahren zum nachweis von nierenkrankheiten und zur pathologischen überwachung
ATE312550T1 (de) Vorrichtung zur segmentären bioimpedanzmessung von einem dialysepatienten
DE602004028312D1 (de) Diagnostischer Teststreifen zum Sammeln und Bestimmen eines Analyts in einer fluiden Probe und Verfahren zur Verwendung desselben
DK1570274T3 (da) Analysator og analysefremgangsmåde og en væskekassette
ATE406834T1 (de) System zur überwachung der konzentration von analyten in körperflüssigkeiten
ATE272211T1 (de) Hochempfindliches, genaues und präzises automatisiertes messverfahren und vorrichtung zur identifizierung und quantifizierung von blutplättchen und zur bestimmung des blutplättchenaktivitätszustands unter verwendung von ganzblutproben
DE50111644D1 (de) Verfahren und vorrichtung zum nachweisen von substanzen in körperflüssigkeiten mittels raman-spektroskopie
DE69910003D1 (de) Überwachung physiologischer analyte
DE69901743D1 (de) Biosensor, iontophoretischen Probenahmesystem, und Verfahren zur seiner Anwendung
DE60315373D1 (de) Vorrichtung und Verfahren zur Bestimmung der Konzentration von Analyten
WO2006128192A3 (en) Use of free circulating dna for diagnosis, prognosis, and treatment of cancer
DE60138829D1 (de) Verfahren zur unterscheidung des reizkolons von der entzündlichen darmerkrankung (inflammatory bowel disease, ibd) und zur überwachung von patienten mit ibd unter verwendung von endogenem gesamt-lactoferrin als marker
DE60034479D1 (de) Vorrichtung und verfahren zum bestimmen der koagulation in flüssigproben
WO2005112742A3 (en) Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same
DE69941627D1 (de) Für krebs
BR9804648A (pt) Monitorização da obediência do paciente ao tratamento e da biodisponibilidade de drogas pela desproteinização de fluidos corpóreos.
DE60232595D1 (de) Methode zur diagnose von nierenerkrankungen
RU2008103988A (ru) Способ диагностики рассеяного склероза
Xu et al. Simultaneous determination of urinary creatinine, calcium and other inorganic cations by capillary zone electrophoresis with indirect ultraviolet detection
DE60025170D1 (de) Diagnostisches verfahren für asthma
WO2002057793A3 (en) Method of detecting prp protein and kits therefor
ATE302947T1 (de) Verfahren zum nachweis eines lipoprotein- akutphaseprotein-komplexes
NO20034059D0 (no) Fremgangsmåte for screening av pre-diabetiske tilstander og screening-reagens
ATE139803T1 (de) Allelische verbindung des humanen dopamin- (d2)rezeptor-gens in kompulsionsstörungen wie alkoholismus
FR2805545B1 (fr) Procede electrochimique de detection d'acides nucleiques

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties